157
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Ceca–Cyclophosphamide, Etoposide, Carboplatin and Cytosine Arabinoside–A New Salvage Regimen for Relapsed or Refractory Acute Myelogenous Leukemia

, , , , , , & show all
Pages 371-375 | Received 01 May 1997, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Lance H. Leopold & Roel Willemze. (2002) The Treatment of Acute Myeloid Leukemia in First Relapse: A Comprehensive Review of the Literature. Leukemia & Lymphoma 43:9, pages 1715-1727.
Read now
Chkistelle Ferrá, Jcan J. Berlanga, David Gallardo, Idoia AncIan, David MarIan, Juan R Gonzaalez, Juan Peris, Juan Muñoz, Josæ Sarraa & Alberto Grañena. (2000) Mitoxantrone, Etoposide, Carboplatinum and Ara-C Combination Therapy (Meca) in Refractory and Relapsed Acute Leukemia. Leukemia & Lymphoma 39:5-6, pages 583-590.
Read now
Amine Belhabri, Xavier Thomas, Jacques Troncy, David Assouline, Mauricette Michallet, Eric Wattel, Jean Dominique Tigaud, Michel Blanc, Denis Fiére & Eric Archimbaud. (1999) Continuous-Infusion Carboplatin in Combination with Idarubicin or Mitoxantrone for High-Risk Acute Myeloid Leukemia: A Randomised Phase II Study. Leukemia & Lymphoma 36:1-2, pages 45-55.
Read now

Articles from other publishers (4)

Jonas Westhus, Richard Noppeney, Christine Schmitz, Michael Flasshove, Ulrich Dührsen & Maher Hanoun. (2020) Etoposide Combined with FLAG Salvage Therapy Is Effective in Multiple Relapsed/Refractory Acute Myeloid leukemia. Acta Haematologica 143:5, pages 438-445.
Crossref
Juan Eduardo Megías-Vericat, David Martínez-Cuadrón, Miguel Ángel Sanz & Pau Montesinos. (2018) Salvage regimens using conventional chemotherapy agents for relapsed/refractory adult AML patients: a systematic literature review. Annals of Hematology 97:7, pages 1115-1153.
Crossref
Jonathan E. Kolitz. 2006. Oncology. Oncology 1160 1181 .
Lance H. Leopold, Mark S. Berger & Jay Feingoldr. (2002) Acute and Long-Term Toxicities Associated with Gemtuzumab Ozogamicin (Mylotarg®) Therapy of Acute Myeloid Leukemia. Clinical Lymphoma 2, pages S29-S34.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.